Turnover: ()
Country: France
Biotech specializing in the production of insulin for the treatment of diabetes
News
DiogenX: 27.5 million euros for its promising diabetes therapy 11/05/2023
- DiogenX's first round of financing in June 2020: 4.5 million euros
- Capital raising: 27.5 million euros in 2023
- Insulin therapy market: €63 billion, dominated by Novo Nordisk, Eli Lilly and Sanofi.
- Annual growth rate in the number of people with type 1 diabetes: 3% to 4%
- Type 1 diabetes accounts for 10% of diabetes cases worldwide
- Estimated number of people with type 1 diabetes in 2040: 17 million
- current DiogenX team: 15 people.
> Besoin de plus d'information sur cette entreprise (SWOT, PESTEL, son marché) ? Demandez à SectorGPT (gratuit)
Sector-GPT est la première IA dédiée aux informations sectorielles.